Trial Profile
Efficacy and Safety of Tofacitinib in patients with severe active Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jan 2020
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary) ; Corticosteroids; Leflunomide; Methotrexate; Prednisone
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 15 Jun 2019 Results (n=26) investigating the effect of tofacitinib on the levels of NT-proBNP during 12-Month Follow-Up, presented at the 20th Annual Congress of the European League Against Rheumatism.
- 17 Jun 2017 Results (n=28) evaluating the effects of tofacitinib on cardiovascular risk factors in rheumatoid arthritis patients during 12-month follow-up, presented at the 18th Annual Congress of the European League Against Rheumatism.
- 17 Jun 2017 Pooled results the safety and efficacy of Tofacitinib in patients from this this and one another study (n=142), presented at the 18th Annual Congress of the European League Against Rheumatism